<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-ijms-21-09049">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Weidner</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Wowro</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Freiwald</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kawamoto</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Witzke</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kliem</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Siems</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Müller-Kuhrt</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Schroeder</surname>
    <given-names>F.C.</given-names>
   </name>
   <name>
    <surname>Sauer</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPARγ) agonist with potent glucose-lowering properties</article-title>
  <source>Diabetology</source>
  <year>2013</year>
  <volume>56</volume>
  <fpage>1802</fpage>
  <lpage>1812</lpage>
  <pub-id pub-id-type="doi">10.1007/s00125-013-2920-2</pub-id>
  <?supplied-pmid 23680913?>
  <pub-id pub-id-type="pmid">23680913</pub-id>
 </element-citation>
</ref>
